Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001383851 | SCV001583160 | pathogenic | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This missense change has been observed in individuals with clinical features of autosomal recessive retinitis pigmentosa (PMID: 24625443, 28041643, 29659094; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 727 of the MERTK protein (p.Arg727Gln). ClinVar contains an entry for this variant (Variation ID: 236454). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg727 amino acid residue in MERTK. Other variant(s) that disrupt this residue have been observed in individuals with MERTK-related conditions (PMID: 28041643), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MERTK protein function. |
Centre for Genomic Medicine, |
RCV000225669 | SCV000282560 | uncertain significance | Retinal dystrophy | no assertion criteria provided | clinical testing | ||
NIHR Bioresource Rare Diseases, |
RCV000505072 | SCV000598748 | likely pathogenic | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research |